Phase II: breakdown of standardised scenarios
| Acuity | Age | |||||||
|---|---|---|---|---|---|---|---|---|
| Complaint type | Red | Orange | Yellow | Green | Adult | Ped | Frequency | Percentage |
| Cardiothoracic | 3 | 1 | 3 | 3 | 6 | 4 | 10 | 15.9 |
| ENT/eye | 1 | 0 | 4 | 2 | 4 | 3 | 7 | 11.1 |
| Fever | 0 | 1 | 3 | 2 | 3 | 3 | 6 | 9.5 |
| Genitourinary | 0 | 1 | 4 | 2 | 4 | 3 | 7 | 11.1 |
| Gastrointestinal | 0 | 1 | 4 | 2 | 3 | 4 | 7 | 11.1 |
| Neurology | 0 | 2 | 4 | 1 | 4 | 3 | 7 | 11.1 |
| Trauma/musculoskeletal | 1 | 2 | 4 | 2 | 6 | 3 | 9 | 14.3 |
| Toxicology/skin | 0 | 0 | 5 | 1 | 3 | 3 | 6 | 9.5 |
| General orange | 0 | 2 | 0 | 0 | 1 | 1 | 2 | 3.2 |
| General red | 2 | 0 | 0 | 0 | 1 | 1 | 2 | 3.2 |
| Total | 7 | 10 | 31 | 15 | 35 | 28 | 63 | 100 |
ENT, ear, nose, throat; Ped, Paediatrics.